glp 1 and metabolic syndrome The effect of GLP-1R agonists on the medical triad of obesity, diabetes, cancer | Cancer and Metastasis Reviews glp 1 metabolic syndrome GLP-1

"These offers follow the recent agreement with the US Administration to expand access to medicines for patients living with obesity and other chronic conditions like diabetes, while lowering prices in the direct-to-patient, self-pay channel in 2026 and today, Novo Nordisk is bringing these prices to consumers months in advance of that commitment," the company statement read

It slows gastric emptying so food stays in your stomach longer

That gas exits as a burp with a characteristic rotten-egg odor

Healthcare providers are encouraged to report any suspected adverse events, including mental health changes, through the FDA's MedWatch program